MedPath

Symax SR

Symax -SR

Approved
Approval ID

d1bb2ea1-cde8-4f3b-93b6-04c7a441f453

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 22, 2023

Manufacturers
FDA

Capellon Pharmaceuticals, LLC

DUNS: 124568093

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hyoscyamine Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code64543-112
Product Classification
G
Generic Name
Hyoscyamine Sulfate
Product Specifications
Route of AdministrationORAL
Effective DateAugust 22, 2023
FDA Product Classification

INGREDIENTS (9)

ETHYLCELLULOSESInactive
Code: 7Z8S9VYZ4B
Classification: IACT
CALCIUM PHOSPHATEInactive
Code: 97Z1WI3NDX
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
HYOSCYAMINE SULFATEActive
Quantity: 0.375 mg in 1 1
Code: F2R8V82B84
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Symax SR - FDA Drug Approval Details